(Q43917199)

28 November 2017

0 references

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs (English)

1 reference

28 November 2017

1 reference

5

Kristine Ensrud

1 reference

28 November 2017

7

Dennis M Black

1 reference

28 November 2017

6

Andrea Z LaCroix

1 reference

28 November 2017

1

Steven R Cummings

1 reference

28 November 2017

4

Harry K Genant

1 reference

28 November 2017

David B Karpf

2

1 reference

28 November 2017

Fran Harris

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

American Journal of Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

112

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

281-289

1 reference

Prediction of vertebral and femoral strength in vitro by bone mineral density measured at different skeletal sites

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Treatment of postmenopausal osteoporosis with transdermal estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Changing perceptions in osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Statistical validation of intermediate endpoints for chronic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Trabecular bone architecture in the pathogenesis and prevention of fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Architecture and vertebral fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Vertebral structure and strength in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Comparison of rates of bone loss from the spine measured using two manufacturers' densitometers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Bone compressive strength: the influence of density and strain rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

A 20-year perspective on the mechanical properties of trabecular bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Bone matters: are density increases necessary to reduce fracture risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Defining incident vertebral deformity: a prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

Statistical Validation of Surrogate Endpoints: Problems and Proposals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901124-X

10.1016/S0002-9343(01)01124-X

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference